Andy’s role is Business Development at Rancho Biosciences. He brings over 30 years’ experience in consultative selling of complex solutions and services to pharma and biotech companies. After gaining his PhD in Computational Chemistry from University College London he spent the first 10 years working at two of the pioneering companies in molecular modeling, Chemical Design and Biosym Technologies. He then spent 7 years at Aspen Technology before joining IBM Healthcare and Lifesciences in 2003. Early in 2009 he joined GeneGo which was acquired by Thomson Reuters in 2011. He spent a further 5 years at TR where he led the Discovery and Translational Sciences business development team for N. America and Europe. After brief stints at Bioreference Labs/GeneDx and Cyclica he joined Rancho Biosciences in January 2019.